Walleye Trading
GPCR icon

Walleye Trading’s Structure Therapeutics GPCR Stock Holding History

Walleye Trading’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,600
Closed -$125K – 4166
2026
Q1 		$125K Sell
2,600
-100
-4% -$6.84K ﹤0.01% 3354
2025
Q4 		$188K Sell
2,700
-23,600
-90% -$964K ﹤0.01% 3419
2025
Q3 		$736K Buy
26,300
+22,600
+611% +$450K ﹤0.01% 2472
2025
Q2 		$76.7K Hold
3,700
– – ﹤0.01% 3698
2025
Q1 		$64K Buy
3,700
+3,600
+3,600% +$88.2K ﹤0.01% 3544
2024
Q4 		$2.71K Buy
+100
New +$3.55K ﹤0.01% 4112
2024
Q3 		– Sell
-300
Closed -$11.8K – 4270
2024
Q2 		$11.8K Sell
300
-3,600
-92% -$148K ﹤0.01% 3848
2024
Q1 		$167K Sell
3,900
-20,200
-84% -$852K ﹤0.01% 3524
2023
Q4 		$982K Buy
+24,100
New +$1.38M ﹤0.01% 2479

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Capitolis Liquid Global Markets
Capitolis Liquid Global Markets New York $22.4B AUM 40.52% 1-Year Est. Return
Pacific Heights Asset Management
Pacific Heights Asset Management San Francisco, California $3.1B AUM 37.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Walleye Trading's GPCR Position: Q3 2026 in Review

Walleye Trading sold out of Structure Therapeutics (GPCR) in Q3 2026, closing a stake of 4,113 shares — an estimated $221K sold.

Walleye Trading first reported a position in GPCR in Q4 2023 and held it in 4 quarters. The position peaked at $566K in Q4 2023. 113 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Walleye Trading reported no remaining Structure Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Walleye Trading sold 4,113 Structure Therapeutics shares in Q3 2026, an estimated $221K.
  • Walleye Trading first reported a position in Structure Therapeutics in Q4 2023 and held it in 4 quarters.
  • Walleye Trading's Structure Therapeutics position peaked at $566K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Walleye Trading's 13F filing for Q3 2026, filed 13 Nov 2026.